Application

18018017 · COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS RELATED TO GLUCOSYLCERAMIDASE BETA DEFICIENCY

Filed 2023-01-25 · Pending The official file ↗ · Art unit 1652 · Examiner Benjamin Hall Easton · CPC C12N 9/2402 · VOYAGER THERAPEUTICS, INC. · Finnegan/Neurocrine Biosciences, Inc.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

33.5 mo

to disposition n/a

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.